Get the latest Science News and Discoveries
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers - EurekAlert
On July 2, 2024, a new research paper was published in Oncotarget, entitled, “Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status.”
None
Or read this on Eureka Alert